Suchergebnisse - "Ritonavir"

PubPharm (372)

1

Virological outcomes and metabolic effects after switching from ritonavir-boosted protease inhibitors to a dolutegravir-based regimen in virologically suppressed patients living with HIV

enthalten in: International journal of STD & AIDS | 2023

von Sribenjalux, W. | Nuntawit, T. | Meesing, A. | +1

2

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Eke, A. | Wang, J. | Amin, K. | +46

3

Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosis

enthalten in: International journal of antimicrobial agents | 2020

von Boulanger, C. | Rolla, V. | Al-Shaer, M. | +1

4

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment : A Prospective, Single-Arm Trial

enthalten in: Journal of the International Association of Providers of AIDS Care | 2019

von Claassen, C. | Keckich, D. | Nwizu, C. | +5

5

Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients

enthalten in: European journal of clinical pharmacology | 2018

von Nagano, D. | Araki, T. | Yanagisawa, K. | +6

6

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia

enthalten in: AIDS (London, England) | 2018

von Leyes, P. | Cofan, M. | González-Cordón, A. | +9

7

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2017

von Cressey, T. | Yogev, R. | Wiznia, A. | +9

8

Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Bartels, H. | Decosterd, L. | Battegay, M. | +1

9

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach : an observational analysis within the randomised, open-label, EARNEST trial

enthalten in: The lancet. HIV | 2017

von Paton, N. | Kityo, C. | Thompson, J. | +112

CommentIn: Lancet HIV. 2017 Aug;4(8):e323-e324. - PMID 28495563

10

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Lombardi, F. | Belmonti, S. | Quiros-Roldan, E. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]